Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New movie: the eating assistive device improved Teddy’s life

In collaboration with the Swedish Agency for Participation and Teddy Nordgren, Camanio describes the value of innovative care technology in a unique and personal story. When his disease made it difficult for Teddy to use his arms and hands, many things in his life changed. Today, he can’t engage in his usual hobbies sports and carpentry, and he needs support in order to make his everyday life function. When he started to use Camanio’s eating assistive device Bestic®, an important part of Teddy’s life improved!To be able to eat by yourself is a central part of an independent life. But not

Fortum and Cyclife start a partnership in nuclear decommissioning services

FORTUM CORPORATION PRESS RELEASE 25 May 2018 Fortum and Cyclife Sweden, part of EDF Group, have signed a partnership to develop commercial services in nuclear decommissioning and waste management focusing on the Nordic market. Through this new partnership, the companies will utilize their complementary competencies and strong experiences in nuclear decommissioning and waste management to offer an extensive service supply and create value for its customers through cost optimization, risk mitigation and interface reduction. With a comprehensive range of services & expertise, Cyclife

Södra promotes timber as a building material in Venice

Södra will be represented at the International Architecture Exhibition in Venice that opens on 26 May. Together with other Swedish operators, Södra will demonstrate timber’s potential as a building material, and also participate in the introductory panel discussion.Södra will be taking part in the collateral event “Greenhouse Garden – Reflect, Project, Connect”*, which includes exhibitions, seminars and workshops. The Serra dei Giardini park will serve as a venue for Swedish events during the exhibition. “Climate-change challenges and growing cities are changing the world. The need for

Coor acquires service company in Norway

Coor has signed an agreement regarding the acquisition of Norwegian facility management operator West Facility Management. West has annual sales of some MSEK 140 and more than 300 employees, mainly based in Bergen and Oslo. The acquisition makes a positive contribution to Coor’s expansion and competences, largely in key cleaning segments. The acquisition of West Facility Management is conditional on approval by the Norwegian Competition Authority.West Facility Management is a Norwegian family-owned company founded in 1980. The company provides cleaning, restaurant and other FM services to

Mantella wins Swedish Steel Prize 2018

The winner of this year’s international Swedish Steel Prize is Mantella S.r.l. from Italy. The prize is awarded for the company’s innovative Stratosphere 3.0 rear tipping semi-trailer, which delivers outstanding performance that goes far beyond current offerings on the market. “Mantella has come up with a unique design that represents an entirely new generation in tipper and body solutions. Skilled design work, smart production methods and fully utilizing the advantages of high-strength and wear-resistant steel made it possible,” says Eva Petursson, Chair of the Swedish Steel

Veidekke ASA: MANDATORY NOTIFICATION OF TRADE

On 24 May 2018 Stiftelsen Veidekkeansattes aksjekjøp (the Veidekke Employee Share Trust) purchased 70 000 Veidekke shares at a price of NOK 92.9377 each. The Trust now holds 713 976 shares. The shares will be resold to employees in Veidekke in the share purchase offer for executives in May 2018, see notification of 14 May 2018. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Jan Carlson appointed Honorary Doctor at Linköping University

(Stockholm, Sweden, May 25, 2018) – Jan Carlson, Chairman, President and CEO at Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, has been appointed Honorary Doctor at the Technical faculty of Linköping University. Jan Carlson holds a MSc in Physics and Electrical Engineering from the Technical faculty at Linköping University and he is appointed Technology Honorary Doctorate for his achievements in Swedish industrial technical research and development. “I feel humble and deeply honored,” said Jan Carlson when appointed. “My

Allotment of shares under LTIP 2015 and subsequent sales of shares by senior executives in Scandi Standard

Scandi Standard AB (publ) has allotted and without consideration delivered a total of 84,887 existing shares in the company to participants in the company’s long-term incentive program that was established by the annual general meeting 2015 (LTIP 2015).A number of participants have informed the company that they intend to sell a portion of their allotted shares in order to cover among other things personal income tax triggered by the allotment. To the company’s knowledge, participants intend to sell approximately 37,000 Scandi Standard shares in connection with the allotment under LTIP

Luxembourg, May 25, 2018

Millicom announces successful completion of consent solicitation for its $500,000,000 6.000% Senior Notes due 2025, and its $500,000,000 5.125% Senior Notes due 2028Millicom International Cellular S.A. ("Millicom") today announces that it has received the requisite consents to amend certain terms of its $500,000,000 6.000% Senior Notes due 2025 (ISIN US600814AM98; CUSIP 600814AM9 and ISIN XS1204091588), and its $500,000,000 5.125% Senior Notes due 2028 (ISIN US600814AN71; CUSIP 600814AN7 and ISIN USL6388GAB60) (each, a "Series of Notes" and together, the "Notes"). The consent solicitation

PHI at the Nordic Microscopy Society meeting, June 25-28

The Nordic Microscopy Society meeting in Lyngby Denmark offers several opportunities to meet with us and to hear about the latest HoloMonitor news.Oral Presentation PHI industrial doctoral student Sofia Kamlund has been invited to give a talk with the title “Characterizing Cancer Stem Cell Movement and Division using Digital Holographic Imaging in Combination with Fluorescence”. The presentation will be held during the session “Imaging multicellular systems, Live imaging of single cells, Correlative Light and Electron Microscopy (CLEM)”, Wednesday June 27 at 13.30-15.00. Sofia will talk

Camurus to present at the Jefferies 2018 Global Healthcare Conference

Lund — 25 May 2018 — Camurus AB (Nasdaq Stockholm; CAMX) today announced that the Company will present at the Jefferies 2018 Healthcare Conference in New York on Tuesday 5 June at 8:30 am local time (EDT). Fredrik Tiberg PhD, President and Chief Executive Officer, will update on the progress on the development pipeline, including the ongoing registration processes of the company’s weekly and monthly buprenorphine depots (CAM2038) under development for treatment of opioid dependence. A webcast of the presentation can be accessed live via Camurus’ website www.camurus.com/investors or at

Significant Achievement for OstomyCure AS and TIES®Solution

Approval for multicenter study “TIES-C03” in major university hospitals in Leeds, UK & Umeå, Sweden. OstomyCure AS has achieved an important milestone on the way to making the revolutionary TIES® Solution available to ileostomy patients, a patient population that has not experienced any major improvements in “standard of care” in the last 30-40 years. The study aims to gather more and longer term clinical data regarding safety, performance and Quality of Life. The study has started at Norrland University Hospital, Umeå, Sweden with Associate Professor Karin Strigård and Prof. Ulf

AZ’s Imfinzi: significant OS in Stage III nsclc

This announcement contains inside information 25 May 2018 07:00 BST    Imfinzi significantly improves overall survival in the Phase IIIPACIFIC trial for unresectable Stage III non-small cell lung cancer    Imfinzi met the second primary endpoint of overall survival which was both statistically-significant and clinically-meaningful at a planned interim analysis     AstraZeneca and MedImmune, its global biologics research and development arm, today announced positive overall survival (OS) results for the Phase III PACIFIC trial, a randomised, double-blinded, placebo-

Lifco acquires German dental laboratory

Lifco has signed an agreement to acquire Flörchinger Zahntechnik that is offering dental prosthetics to dentists in Germany. In 2017, the acquired operation reported net sales of approximately 1,7 MEUR. The business employs around 25 employees and the operation will be consolidated in Business Area Dental. The acquisition will not have any significant effect on Lifco’s earnings or financial position in current financial year. For more information please contact: Per Waldemarson Head of Business Area Dental Phone +46 70 840 00 63 E-mail per.waldemarson@lifco.se Åse

Catena Media establishes position in Australian financial services vertical by acquiring premium stock market news and analysis site

Catena Media plc is acquiring the premium Australian stock market news and analysis site, TheBull.com.au  together with other key sites, such as TheBull.asia  and the domain FatCat.com.au. To build this brand and stay ahead of the competition Catena Media is also acquiring the video-focused sites LearnTrading.com.au and LearnCFDs.com , as well as similar domains, from the author Ashley Jessen, who has published books, articles and several videos on trading. The acquired assets currently generate quarterly sales

Nuevolution completes a directed issue raising gross proceeds of SEK 110m

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.25 May 2018 Nuevolution AB (publ) (“Nuevolution” or the “Company”) has, based on the authorization given by Nuevolution’s Annual General Meeting on 12 October 2017 and in accordance with what the Company indicated in a press release on 24 May 2018, resolved to carry out a directed share issue at a subscription

Neste to acquire the share majority of the Dutch animal fat trader IH Demeter B.V.

Neste Corporation, Press Release, 25 May 2018 at 9 am (EET) Neste, a producer of renewable fuels from waste and residues, and IH Demeter B.V., a trader of animal fats and proteins, have agreed that Neste acquires sole control and 51 % of the shares of IH Demeter B.V., making Neste the controlling shareholder. The current owners shall remain as co-owners. The transaction is awaiting for and is subject to regulatory approval. “This is an important step for Neste in our strategy of building a global waste and residue raw material platform to secure raw material availability and

Internationella Engelska Skolan 2017/2018- Interim Report - (1 July - 31 March 2017/2018)

Progress of operations in the third quarter (January-March) · Total operating income increased by 16.8% year on year, mainly due to a larger student base, and amounted to MSEK 632.3 (541.4)  · The number of students in the Swedish operation at the end of the quarter was 23,971 (21,420)   · There were around 179,000 registrations on waiting lists at the end of the quarter, an increase of some 18,000 (11%) on 31 December 2017, and an increase of some 35,000 (24%) on the corresponding point of the previous year    · EBIT for the quarter decreased by 6.4% on the corresponding

Elekta cancer treatment solutions to have significant impact on patients at Cork University Hospital

CRAWLEY, UK, May 25, 2018 – Elekta (EKTA-B.ST) announced today that Cork University Hospital has ordered five Elekta Versa HD™ linear accelerators, as well as Elekta’s Monaco® treatment planning system, MOSAIQ® oncology information system, and brachytherapy equipment, providing an integrated solution for advanced cancer treatment. Versa HD is designed to improve cancer patient care by combining high definition dynamic radiosurgery treatments and precision radiotherapy in a single platform. Versa HD provides the flexibility to treat a broad spectrum of tumors throughout the body, while

I-Tech AB (publ) has received approval for listing of the company's shares on Nasdaq First North

Nasdaq has approved I-Tech AB (publ) ("I-Tech" or "Company") for listing on Nasdaq First North. The first day of trading in the Company's shares is Monday, May 28, 2018.I-Tech has recently completed a share issue for listing on Nasdaq First North. The share issue raised SEK 38.5 million before issue costs. Assuming that the overallotment option of 275,000 shares is fully utilized, the Company will receive a total of SEK 44.1 million before issue costs. Following the share issue, I-Tech will have around 670 shareholders. Nasdaq's review of I-Tech has now been completed and the Company's

Alexion holds 97.7 percent of the shares in Wilson Therapeutics after the initial acceptance period and declares the offer unconditional

THE OFFER REFERRED TO IN THIS PRESS RELEASE IS NOT BEING MADE, EITHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER, ACCORDING TO LEGISLATION AND REGULATIONS IN SUCH JURISDICTION, WOULD BE PROHIBITED BY APPLICABLE LAW. THE OFFER IS NOT BEING MADE TO (NOR WILL TENDER OF SHARES BE ACCEPTED FROM) PERSONS IN THESE COUNTRIES OR PERSONS IN ANY OTHER JURISDICTIONS WHERE TENDER OF SHARES WOULD DEMAND FURTHER DOCUMENTATION, FILINGS OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED PURSUANT TO SWEDISH LAW.

Redeye and Isofol are inviting to the live broadcast of pre-ASCO on May 28th

In connection to this year's major cancer congress ASCO (American Society of Clinical Oncology ) in Chicago in June, Redeye brings together the seven most interesting cancer companies in the Nordic region for a discussion about the major changes in progress and how the companies position themselves in this fast growing theraputic area worth over $ 100 billion a year.Isofol is presented at 09.40 and will present its clinical activities and the cancer drug candidate, Arfolitixorin, which is primarily intended for the treatment of advanced colorectal cancer. Isofol will

Invitation to 1Q 2018 presentation

Otello Corporation ASA is presenting its 1Q 2018 results on Thursday, May 31, 2018, at 08:00am CET. The presentation will take place at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. A live webcast will be available at: https://otellocorp.com/ir Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i)AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their businesses, capitalizing on a global consumer

Bulletin from Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)

May 24, 2018 – The Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) took place on Thursday, May 24, 2018 in the company´s premises at Tomtebodavägen 23a in Stockholm, Sweden.The complete bulletin from the Annual General Meeting (in the Swedish language) is available on the company’s website, www.indexpharma.com. For more information:Peter Zerhouni, CEOPhone: +46 8 508 847 35E-mail: peter.zerhouni@indexpharma.com PublicationThis information is information that InDex Pharmaceuticals Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse

There are no items matching the current filter
There are no more items matching the current filter
Back to top